The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD

July 25th, 2019

This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo.  I wind up coming down pretty hard on this drug; I think it's hype has vastly outpaced its utility. Get the paper itself at ebrheum.com and follow me on @ebrheum to give feedback! 

Podbean App

Play this podcast on Podbean App